Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review is a research paper published in Translational Lung Cancer Research (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA229618
NCI NIH HHS
Grant: R01 CA204856
National Institutes of Health
Grant: 5R01CA229618-05
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy
National Institutes of Health
Grant: 5R01CA204856-05
Drug repurposing in breast cancer
FWCI
1.17
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis
Additional file 1 of First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis